Evan D. Rosen MD Ph.D
Diabetes, Lipid Metabolism
Professor of Medicine, Harvard Medical School Chief, Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center
Join to View Full Profile
330 Brookline AveE/CLS743Boston, MA 02215
Dr. Rosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Evan Rosen is an endocrinologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from University of Michigan Medical School and has been in practice 23 years. He specializes in diabetes and lipid metabolism and is experienced in insulin resistance.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1997
University of Michigan Medical SchoolClass of 1994
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
MA State Medical License 1998 - 2026
NH State Medical License 2024 - 2024
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue.Margo P Emont, Adam L Essene, Anton Gulko, Nadejda Bozadjieva-Kramer, Christopher Jacobs
Molecular Metabolism. 2025-03-24 - 3 citationsThe GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.Xinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, Leon G Straub, Valentina Pirro
Cell Metabolism. 2025-01-07 - 1 citationsTranscriptional control of metabolism by interferon regulatory factors.Zunair Ahmad, Wahab Kahloan, Evan D Rosen
Nature Reviews. Endocrinology. 2024-10-01
Press Mentions
mTORC2-AKT Signaling to ATP-Citrate Lyase Drives Brown Adipogenesis and De Novo LipogenesisJanuary 29th, 2020
New Discovery on Association Between Calorie Burning Fat and Muscle FunctionAugust 3rd, 2018
Brown Fat Flexes Its MuscleAugust 3rd, 2018- Join now to see all
Grant Support
- Regulation of Lipolysis by OxytocinBETH ISRAEL DEACONESS MEDICAL CENTER2022–2028
- Investigating Human Adipocyte HeterogeneityBETH ISRAEL DEACONESS MEDICAL CENTER2018–2028
- Regulation of Adipose-Lymphatic Cross-talkBETH ISRAEL DEACONESS MEDICAL CENTER2021–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Role of IRF3 in Energy and Glucose HomeostasisBETH ISRAEL DEACONESS MEDICAL CENTER2015–2025
- Regulation Of Nutrient Homeostasis By IRF4National Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
- Epigenomics Of Human Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- EBF Proteins In Adipocyte Differentiation And MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Genomic Determinants Of Leptin ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Novel Transcriptional Pathways In AdipogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
- Role Of Ppargamma In Lineage Determination/PhysiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Ppary Adipogenic Action Control By Covalent ModificationNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Role Of Ppargamma In Lineage Determination/PhysiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2001
- Ppary Adipogenic Action Control By Covalent ModificationNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
